A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

NCT05652543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pandemic

Interventions

BIOLOGICAL: SCTV01E
BIOLOGICAL: Placebo (normal saline)

Sponsor

Sinocelltech Ltd.